Results 181 to 190 of about 11,438 (231)
GC-MS/MS analysis of synthetic cannabinoids 5F-MDMB-PICA and 5F-CUMYL-PICA in forensic cases. [PDF]
BioanalysisAhmed H, Mujeebuddin S.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Synthetic Cannabinoids Phenomenon
Current Pharmaceutical Design, 2017« Spice » is generally used to describe the diverse types of herbal blends that encompass synthetic cannabinoids on the market. The emergence of smokable herbal products containing synthetic cannabinoids, which mimic the effects of cannabis, appears to become increasingly popular, in the new psychoactive substances landscape.
Joel Billieux +2 more
exaly +4 more sources
Synthetic cannabinoids: Analysis and metabolites
Life Sciences, 2014Cannabimimetics (commonly referred to as synthetic cannabinoids), a group of compounds encompassing a wide range of chemical structures, have been developed by scientists with the hope of achieving selectivity toward one or the other of the cannabinoid receptors CB1 and CB2.
Waseem Gul +2 more
exaly +3 more sources
Regulation of synthetic cannabinoids
The Lancet, 2009www.thelancet.com Vol 374 November 7, 2009 1595 5 Fuccio L, Zagari RM, Minardi ME, et al. Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer. Aliment Pharmacol Ther 2007; 25: 133–41. As Greta McLachlan reports, the UK Advisory Council for the Misuse of Drugs (ACMD) and the European Monitoring Centre for Drugs and ...
C Heather, Ashton, P Brian, Moore
openaire +4 more sources
The American Journal of the Medical Sciences, 2015
Synthetic cannabinoids (SCBs), also known under the brand names of "Spice," "K2," "herbal incense," "Cloud 9," "Mojo" and many others, are becoming a large public health concern due not only to their increasing use but also to their unpredictable toxicity and abuse potential.
Brooke, Mills +2 more
openaire +2 more sources
Synthetic cannabinoids (SCBs), also known under the brand names of "Spice," "K2," "herbal incense," "Cloud 9," "Mojo" and many others, are becoming a large public health concern due not only to their increasing use but also to their unpredictable toxicity and abuse potential.
Brooke, Mills +2 more
openaire +2 more sources
Focus on cannabinoids and synthetic cannabinoids
Clinical Pharmacology & Therapeutics, 2016The recent emergence of a multitude of synthetic cannabinoids (SCs) has generated a wealth of new information, suggesting the usefulness of state‐of‐the‐art on lato sensu cannabinoids. By modulating a plurality of neurotransmission pathways, the endocannabinoid system is involved in many physiological processes that are increasingly explored.
R, Le Boisselier +3 more
openaire +2 more sources
Psychosis and synthetic cannabinoids
Psychiatry Research, 2018Synthetic cannabinoid (SC) products have gained popularity as abused drugs over the past decade in many countries. The SCs broadly impact psychological state (e.g., mood, suicidal thoughts and psychosis) and physiological functions (e.g., cardiovascular, gastrointestinal and urinary).
Huiqiong Deng +3 more
openaire +2 more sources
2023
New synthetic cannabinoid agonists have been synthesized during the last decades and promoted for their psychoactive effects, mimicking those of delta-9-tetrahydrocannabinol. These newest cannabimimetic drugs show binding affinities for the cannabinoid CB1 and/or the CB2 receptors.
Fattore, Liana, Marti, Matteo
openaire +2 more sources
New synthetic cannabinoid agonists have been synthesized during the last decades and promoted for their psychoactive effects, mimicking those of delta-9-tetrahydrocannabinol. These newest cannabimimetic drugs show binding affinities for the cannabinoid CB1 and/or the CB2 receptors.
Fattore, Liana, Marti, Matteo
openaire +2 more sources
Nonpsychotropic Synthetic Cannabinoids
Current Pharmaceutical Design, 2000Unlike natural cannabinoids which belong to the 6aR - trans series, the synthetic dexanabinol (HU-211), a 6aS-trans enantiomer, does not have affinity toward cannabinoid receptors and is devoid of cannabimimetic activity. On the other hand, dexanabinol demonstrated significant neuroprotective properties which prompted its development as a therapeutic ...
openaire +2 more sources